CRISPR THERAPEUTICS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.91 USD | +0.34% |
|
-2.07% | -13.88% |
| Apr. 18 | Citigroup Adjusts CRISPR Therapeutics' Price Target to $89 From $88, Keeps Buy Rating | MT |
| Apr. 17 | Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 65.19 | 89.12 | 83.99 |
| Spread/Res. | -17.30% | -39.51% | -35.81% |
| Spread/Supp. | +0.34% | +39.16% | +39.59% |
| Support | 53.73 | 38.74 | 38.62 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- CRSP Stock
- Charts CRISPR Therapeutics AG
